{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Hope for Hypermobility: Part 2--An Integrative Approach to Treating Symptomatic Joint Hypermobility

Activity Steps

Description

NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the components of multimodal pain management for individuals with joint hypermobility.
  2. Examine the anticipated outcomes of specific treatment recommendations for improving pain, function, and quality of life for patients with symptomatic joint hypermobility.
  3. Explain the importance of sequence of treatments to determine which are effective for each patient.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of an integrative approach to symptomatic joint hypermobility by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $49.00

Credits:

  • ANCC 2.5 CH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH
  • NM - BON 2.5 CH
  • SC - BON 2.5 CH
  • WV - BOERN 2.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: TPM0423
Published: April 2023
Expires: 3/6/2026
Required Passing Score: 7/10 (70%)
Authors: Victoria Daylor, BFA; Cortney Gensemer, PhD; Russell A. Norris, PhD; Linda Bluestein, MD